Analysed Takeda Pharmaceutical Co Ltd (TAK:NYSE) News Sources
US FDA accepts Takeda and Protagonist’s NDA and grants priority review status for rusfertide as a potential first-in-class therapy for polycythaemia vera
Pharmabiz
HUTCHMED (China) Limited: HUTCHMED Reports 2025 Full Year Results and Business Updates
FinanzNachrichten.de
Faron and City of Hope in Process of Developing a Phase II Investigator-Initiated Trial of Bexmarilimab in Relapsed/Refractory MDS
Le Lézard
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Markets Insider
Global Implanted Brain-Computer Interface Devices Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight
Bolsamania
What is the current price of Takeda Pharmaceutical Co Ltd (TAK:NYSE)?
The current price of Takeda Pharmaceutical Co Ltd (TAK:NYSE) is $17.88.
Takeda Pharmaceutical Co Ltd (TAK:NYSE) absolute price change since previous trading day?
The absolute price change of Takeda Pharmaceutical Co Ltd (TAK:NYSE) since the previous trading day is $0.13.
Takeda Pharmaceutical Co Ltd (TAK:NYSE) percentage price change since previous trading day?
The percentage price change of Takeda Pharmaceutical Co Ltd (TAK:NYSE) since the previous trading day is 0.73%.
What is This Week's average sentiment score for Takeda Pharmaceutical Co Ltd (TAK:NYSE)?
This Week's average sentiment score for Takeda Pharmaceutical Co Ltd (TAK:NYSE) is 69 out of 100.
What is This Week's average sentiment for Takeda Pharmaceutical Co Ltd (TAK:NYSE)?
This Week's sentiment for Takeda Pharmaceutical Co Ltd (TAK:NYSE) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.